Cowen And Company, LLC Fulcrum Therapeutics, Inc. Transaction History

Cowen And Company, LLC

$3.91 Billion
Q2 2024

A detailed history of Cowen And Company, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 2,964,127 shares of FULC stock, worth $9.6 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

2,964,127

Previous 3,713,934 20.19%

Holding current value

$9.6 Million

Previous $35.1 Million 47.58%

% of portfolio

0.47%

Previous 1.18%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$5.98 - $9.31 $4.48 Million - $6.98 Million	-749,807 Reduced 20.19%	2,964,127 $18.4 Million
Q1 2024 May 03, 2024	BUY	$6.7 - $12.0 $1.61 Million - $2.88 Million	240,000 Added 6.91%	3,713,934 $35.1 Million
Q4 2023 Feb 12, 2024	BUY	$3.18 - $6.86 $11 Million - $23.8 Million	3,473,934 New	3,473,934 $23.4 Million
Q3 2023 Nov 09, 2023	BUY	$3.25 - $6.08 $3.87 Million - $7.24 Million	1,191,363 Added 38.22%	4,308,359 $19.1 Million
Q2 2023 Aug 07, 2023	BUY	$2.26 - $3.8 $2.13 Million - $3.58 Million	940,951 Added 43.24%	3,116,996 $10.3 Million
Q1 2023 May 09, 2023	BUY	$2.83 - $13.99 $2.31 Million - $11.4 Million	814,876 Added 59.87%	2,176,045 $6.2 Million
Q4 2022 Feb 09, 2023	SELL	$5.01 - $8.35 $4.94 Million - $8.24 Million	-986,820 Reduced 42.03%	1,361,169 $9.91 Million
Q3 2022 Nov 14, 2022	SELL	$4.92 - $9.1 $186,448 - $344,853	-37,896 Reduced 1.59%	2,347,989 $19 Million
Q2 2022 Aug 05, 2022	SELL	$4.2 - $24.0 $4.48 Million - $25.6 Million	-1,067,486 Reduced 30.91%	2,385,885 $11.7 Million
Q1 2022 May 16, 2022	BUY	$9.96 - $23.65 $34.4 Million - $81.7 Million	3,453,371 New	3,453,371 $81.7 Million
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $21.8 Million - $44.4 Million	-1,560,563 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.28 - $30.97 $1.75 Million - $7.45 Million	240,676 Added 18.23%	1,560,563 $44 Million
Q2 2021 Aug 13, 2021	BUY	$8.09 - $12.0 $3.54 Million - $5.26 Million	438,055 Added 49.68%	1,319,887 $13.8 Million
Q1 2021 May 04, 2021	BUY	$10.94 - $15.32 $9.65 Million - $13.5 Million	881,832 New	881,832 $10.4 Million

Others Institutions Holding FULC

# of Institutions

136

Shares Held

59.2M

Call Options Held

4.32M

Put Options Held

307K

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Account

Cowen And Company, LLC Fulcrum Therapeutics, Inc. Transaction History